PDEX

PRO DEX INC

Nasdaq · Surgical & Medical Instruments & Apparatus · CIK 0000788920
$65.00 -0.32% $207.5M
4 New Institutional Positions
Vol
Market Cap$207.5M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (86%)
Inst. Holders6 funds
Inst. Value$6.2M
Inst. Activity4 buys / 0 sells
Insider Activity0B / 2S
Insider Net $-$294.7K
SEC Reports1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·CIK 0000788920·Prev Close $65.21

Recent Activity

May 22, 2026 Insider
Van Kirk Richard Lee Jr sold 2,824 shares
Chief Executive Officer @ $62.09 ($175.3K)
May 21, 2026 Insider
Van Kirk Richard Lee Jr sold 1,918 shares
Chief Executive Officer @ $62.22 ($119.3K)
Apr 30, 2026 SEC
Pro-Dex reported record Q3 FY2026 revenue of $19.9M (+15% YoY), driven by next-gen handpiece shipments to its largest cu
8-K — Impact 5/10
Inst.
MORGAN STANLEY — ADD
3,972 shares ($152.8K)
Inst.
WELLS FARGO & COMPANY/MN — ADD
2,314 shares ($89.0K)
Apr 30, 2026 earnings_calendar
PDEX Q3 2026 Earnings Scheduled — 2026-04-30

Price Targets

$70.00 +7.7% upside Buy
Current $65.00 Low $70.00 Median $70.00 High $70.00 1 analysts
$70.00 $70.00

Analyst Ratings

Strong Buy86% buy · 7 analysts
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
DateFirmActionRating
May 12, 2026 Ascendiant Capital MAINTAIN Buy → Buy

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$5.6M
CHARLES SCHWAB INVESTMENT MANAGEMENT$277.5KNEW
MORGAN STANLEY$152.8KADD
WELLS FARGO & COMPANY/MN$89.0KADD
BANK OF AMERICA CORP$69.6KADD

Recent Insider Trades

DateInsiderTypeValue
May 22, 2026Van KirkSELL$175.3K
May 21, 2026Van KirkSELL$119.3K
6 institutional holders with $6.2M total value (160,531 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 4 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC144,571$5.6M90.1%
2CHARLES SCHWAB INVESTMENT MANAGEMENT INC7,211$277.5K4.5%NEW
3MORGAN STANLEY3,972$152.8K2.5%ADD +61.1%
4WELLS FARGO & COMPANY/MN2,314$89.0K1.4%ADD +65.4%
5BANK OF AMERICA CORP /DE/1,808$69.6K1.1%ADD +69.0%
6FMR LLC655$25.2K0.4%DOUBLED +3993.8%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
MORGAN STANLEYADD2,4653,972+61.1%$152.8K2025-Q4
WELLS FARGO & COMPANY/MNADD1,3992,314+65.4%$89.0K2025-Q4
BANK OF AMERICA CORP /DE/ADD1,0701,808+69.0%$69.6K2025-Q4
FMR LLCDOUBLED16655+3993.8%$25.2K2025-Q4
UBS Group AGADD7,8719,902+25.8%$335.2K2025-Q3
MORGAN STANLEYTRIM4,2322,465-41.8%$83.4K2025-Q3
BANK OF AMERICA CORP /DE/TRIM1,6921,070-36.8%$36.2K2025-Q3
FMR LLCDOUBLED516+220.0%$539.002025-Q3
RENAISSANCE TECHNOLOGIES LLCEXIT11,2400-100.0%$0.002025-Q3
RENAISSANCE TECHNOLOGIES LLCTRIM15,24011,240-26.2%$490.5K2025-Q2
CHARLES SCHWAB INVESTMENT MANAGEMENT INCNEW7,211$314.7K2025-Q2
MORGAN STANLEYTRIM7,4604,232-43.3%$184.7K2025-Q2
BANK OF AMERICA CORP /DE/DOUBLED6191,692+173.3%$73.8K2025-Q2
WELLS FARGO & COMPANY/MNNEW1,194$52.1K2025-Q2
FMR LLCNEAR_EXIT7055-99.3%$216.002025-Q2
CITADEL ADVISORS LLCNEW8,650$428.9K2025-Q1
UBS Group AGADD6,1168,027+31.2%$398.0K2025-Q1
MORGAN STANLEYTRIM17,8517,460-58.2%$369.9K2025-Q1
UBS Group AGADD4,3676,116+40.1%$285.9K2024-Q4
1 unique insiders with 2 transactions. Net insider value: -$294.7K ($0.00 bought, $294.7K sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 22, 2026Van Kirk Richard Lee JrChief Executive OfficerSELL2,824$62.09$175.3K
May 21, 2026Van Kirk Richard Lee JrChief Executive OfficerSELL1,918$62.22$119.3K
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 0 neutral. Avg impact: 5.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Strong Buy (86% buy). Based on 7 analysts: 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$70.00 mean target +7.7% upside Buy (3.00)
$70.00 Low $70.00 High
MetricValue
Current Price$65.00
Target Low$70.00
Target Mean$70.00
Target Median$70.00
Target High$70.00
# Analysts1
RecommendationBuy (3.00)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.00 $0.00 $0.00 $0.0B 9.8%
Next Q
2026-09-30
$0.00 $0.00 $0.00 $0.0B 5.8%
Current FY
2026-06-30
$0.00 $0.00 $0.00 $0.1B 14.7%
Next FY
2027-06-30
$0.00 $0.00 $0.00 $0.1B 6.0%
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 12, 2026 Ascendiant Capital MAINTAIN Buy Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20262410086%
Feb 1, 20262410086%
Jan 1, 20262410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Apr 30, 2026
earnings_calendar
PDEX Q3 2026 Earnings Scheduled — 2026-04-30
Apr 29, 2026
earnings_calendar
PDEX Q3 2026 Earnings Scheduled — 2026-04-29